Options Brief: Salix Pharmaceuticals, Ltd.

Shares of Salix Pharmaceuticals, Ltd. SLXP are higher on the session by 1.17%, trading at $37.12. Overall call volume is now running at 19.35x the daily average, with 0% of all calls traded being purchases on the offer. 1,045 contracts have traded on the session so far. Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are affecting the digestive tract.